TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Do Elastic Abdominal Binders Reduce Post Operative Pain and Blood Loss?
Brief Summary: This is a pilot study investigating the use of abdominal binders after cesarean sections. The researchers are testing whether elastic abdominal binders improve postoperative pain control and reduce postoperative blood loss. Blood loss and pain control are both concerns after giving birth. It is hoped that the use of an abdominal binder after giving birth will provide a non-pharmacologic way to to reduce blood loss and manage pain.


Options:
A: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Device: Procare abdominal binder | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard of Care | Intervention Type: DEVICE; Name: Procare abdominal binder; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: Standard of Care; Assigned to Arm(s): Control
B: Arm Label: SofPulse nonfunctional device.; Type: PLACEBO_COMPARATOR; Interventions: Device: SofPulse | Arm Label: Active; Type: ACTIVE_COMPARATOR; Interventions: Device: SofPulse | Intervention Type: DEVICE; Name: SofPulse; Assigned to Arm(s): Active, SofPulse nonfunctional device.
C: Arm Label: Active device; Type: ACTIVE_COMPARATOR; Interventions: Device: Pulsed electromagnetic field device (ActiPatch TM) | Arm Label: Placebo - inactive device; Type: PLACEBO_COMPARATOR; Interventions: Device: Inactive pulsed electromagnetic field device (ActiPatch TM) | Intervention Type: DEVICE; Name: Pulsed electromagnetic field device (ActiPatch TM); Assigned to Arm(s): Active device | Intervention Type: DEVICE; Name: Inactive pulsed electromagnetic field device (ActiPatch TM); Assigned to Arm(s): Placebo - inactive device
D: Arm Label: abdominal binder; Type: ACTIVE_COMPARATOR; Interventions: Device: abdominal Binder | Arm Label: No Abdominal Binder; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: abdominal Binder; Assigned to Arm(s): abdominal binder

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Serious Illness Communication Project
Brief Summary: The purpose of the study is to evaluate the impact of implementing a "Serious Illness Conversation Guide" to guide patient/family-clinician discussions and planning about end-of-life care decisions. The goal of the intervention is to improve achievement of patient care priorities and peacefulness at the end of life for patients with serious and life-threatening illness and their families. We hypothesize that patients whose physician is trained to use and adheres to the elements of the Serious Illness Conversation Guide will demonstrate enhanced consistency between documented key priorities and care received, and will experience greater peace in the final month of life; similarly, their families will experience higher satisfaction with care.


Options:
A: Intervention Type: OTHER; Name: educational intervention; Assigned to Arm(s): N/A | Intervention Type: OTHER; Name: internet-based intervention; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: evaluation of cancer risk factors; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: fecal occult blood test; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: screening colonoscopy; Assigned to Arm(s): N/A
B: Arm Label: Trained Clinicians; Type: EXPERIMENTAL; Interventions: Behavioral: Training | Arm Label: Non-trained Clinicians; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Non-volunteer Clinicians; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Training; Assigned to Arm(s): Trained Clinicians
C: Intervention Type: BEHAVIORAL; Name: smoking cessation intervention; Assigned to Arm(s): N/A | Intervention Type: OTHER; Name: counseling intervention; Assigned to Arm(s): N/A
D: Arm Label: Alert Group; Type: EXPERIMENTAL; Interventions: Other: Electronic alert and the Geneva Risk Score calculation tool issued in the electronic patient chart | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Electronic alert and the Geneva Risk Score calculation tool issued in the electronic patient chart; Assigned to Arm(s): Alert Group

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Serious Illness Communication Project
Brief Summary: The purpose of the study is to evaluate the impact of implementing a "Serious Illness Conversation Guide" to guide patient/family-clinician discussions and planning about end-of-life care decisions. The goal of the intervention is to improve achievement of patient care priorities and peacefulness at the end of life for patients with serious and life-threatening illness and their families. We hypothesize that patients whose physician is trained to use and adheres to the elements of the Serious Illness Conversation Guide will demonstrate enhanced consistency between documented key priorities and care received, and will experience greater peace in the final month of life; similarly, their families will experience higher satisfaction with care.


Options:
A: Arm Label: video decision aid; Type: EXPERIMENTAL; Interventions: Behavioral: video decision aid | Arm Label: Usual Care -- Verbal Description Arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: video decision aid; Assigned to Arm(s): video decision aid
B: Arm Label: ICU Usual Care Control; Type: ACTIVE_COMPARATOR; Interventions: Other: ICU Usual Care Control | Arm Label: The PARTNER Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: The PARTNER Intervention | Intervention Type: BEHAVIORAL; Name: The PARTNER Intervention; Assigned to Arm(s): The PARTNER Intervention | Intervention Type: OTHER; Name: ICU Usual Care Control; Assigned to Arm(s): ICU Usual Care Control
C: Arm Label: Trained Clinicians; Type: EXPERIMENTAL; Interventions: Behavioral: Training | Arm Label: Non-trained Clinicians; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Non-volunteer Clinicians; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Training; Assigned to Arm(s): Trained Clinicians
D: Arm Label: standard of care health decision making; Type: ACTIVE_COMPARATOR; Interventions: Other: standard of care | Arm Label: TAILORED intervention; Type: EXPERIMENTAL; Interventions: Other: TAILORED Patient Family Decision Making | Intervention Type: OTHER; Name: TAILORED Patient Family Decision Making; Assigned to Arm(s): TAILORED intervention | Intervention Type: OTHER; Name: standard of care; Assigned to Arm(s): standard of care health decision making

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Serious Illness Communication Project
Brief Summary: The purpose of the study is to evaluate the impact of implementing a "Serious Illness Conversation Guide" to guide patient/family-clinician discussions and planning about end-of-life care decisions. The goal of the intervention is to improve achievement of patient care priorities and peacefulness at the end of life for patients with serious and life-threatening illness and their families. We hypothesize that patients whose physician is trained to use and adheres to the elements of the Serious Illness Conversation Guide will demonstrate enhanced consistency between documented key priorities and care received, and will experience greater peace in the final month of life; similarly, their families will experience higher satisfaction with care.


Options:
A: Arm Label: Nueva Vida Intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Nueva Vida Intervention | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Nueva Vida Intervention; Assigned to Arm(s): Nueva Vida Intervention
B: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Communication training and coaching | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Communication training and coaching; Assigned to Arm(s): Intervention
C: Arm Label: Trained Clinicians; Type: EXPERIMENTAL; Interventions: Behavioral: Training | Arm Label: Non-trained Clinicians; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Non-volunteer Clinicians; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Training; Assigned to Arm(s): Trained Clinicians
D: Arm Label: Intervention Arm; Type: EXPERIMENTAL; Interventions: Behavioral: Training Program Intervention | Arm Label: Control Arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Training Program Intervention; Assigned to Arm(s): Intervention Arm

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Serious Illness Communication Project
Brief Summary: The purpose of the study is to evaluate the impact of implementing a "Serious Illness Conversation Guide" to guide patient/family-clinician discussions and planning about end-of-life care decisions. The goal of the intervention is to improve achievement of patient care priorities and peacefulness at the end of life for patients with serious and life-threatening illness and their families. We hypothesize that patients whose physician is trained to use and adheres to the elements of the Serious Illness Conversation Guide will demonstrate enhanced consistency between documented key priorities and care received, and will experience greater peace in the final month of life; similarly, their families will experience higher satisfaction with care.


Options:
A: Arm Label: Intervention group 1; Type: EXPERIMENTAL; Interventions: Other: Questionnaire administration | Arm Label: Intervention group 2; Type: EXPERIMENTAL; Interventions: Other: Questionnaire administration | Arm Label: Control group 1; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Control group 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Questionnaire administration; Assigned to Arm(s): Intervention group 1, Intervention group 2
B: Arm Label: Trained Clinicians; Type: EXPERIMENTAL; Interventions: Behavioral: Training | Arm Label: Non-trained Clinicians; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Non-volunteer Clinicians; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Training; Assigned to Arm(s): Trained Clinicians
C: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Intervention | Arm Label: Attention; Type: EXPERIMENTAL; Interventions: Other: Attention | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Other: Control | Intervention Type: OTHER; Name: Intervention; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: Attention; Assigned to Arm(s): Attention | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): Control
D: Arm Label: intervention group; Type: ACTIVE_COMPARATOR; Interventions: Device: distress thermometer | Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: distress thermometer; Assigned to Arm(s): intervention group

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Impact of Resistance Training During Hospitalization in COPD Patients: a Randomized and Controlled Trial
Brief Summary: The purpose of this study is to determine whether resistance exercise are effective in combating the decline in muscle strength during an exacerbation of Chronic Obstructive Pulmonary Disease (COPD).


Options:
A: Arm Label: Arm A (myAIRVO2® + HOT, HOT); Type: EXPERIMENTAL; Interventions: Device: High-flow nasal cannula therapy, Device: Home oxygen therapy (HOT) | Arm Label: Arm B (HOT, myAIRVO2® + HOT); Type: EXPERIMENTAL; Interventions: Device: High-flow nasal cannula therapy, Device: Home oxygen therapy (HOT) | Intervention Type: DEVICE; Name: High-flow nasal cannula therapy; Assigned to Arm(s): Arm A (myAIRVO2® + HOT, HOT), Arm B (HOT, myAIRVO2® + HOT) | Intervention Type: DEVICE; Name: Home oxygen therapy (HOT); Assigned to Arm(s): Arm A (myAIRVO2® + HOT, HOT), Arm B (HOT, myAIRVO2® + HOT)
B: Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Coaching program; Type: EXPERIMENTAL; Interventions: Other: Coaching program | Intervention Type: OTHER; Name: Coaching program; Assigned to Arm(s): Coaching program
C: Arm Label: resistance training; Type: EXPERIMENTAL; Interventions: Other: Resistance training | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Resistance training; Assigned to Arm(s): resistance training
D: Arm Label: Inspiratory Muscle Training; Type: EXPERIMENTAL; Interventions: Procedure: Inspiratory Muscle Training | Arm Label: Sham IMT; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Inspiratory Muscle Training | Intervention Type: PROCEDURE; Name: Inspiratory Muscle Training; Assigned to Arm(s): Inspiratory Muscle Training, Sham IMT

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Impact of Resistance Training During Hospitalization in COPD Patients: a Randomized and Controlled Trial
Brief Summary: The purpose of this study is to determine whether resistance exercise are effective in combating the decline in muscle strength during an exacerbation of Chronic Obstructive Pulmonary Disease (COPD).


Options:
A: Arm Label: resistance training; Type: EXPERIMENTAL; Interventions: Other: Resistance training | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Resistance training; Assigned to Arm(s): resistance training
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: Resistance training | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Other: Usual care | Intervention Type: OTHER; Name: Resistance training; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: Usual care; Assigned to Arm(s): 2
C: Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: EPR; Type: EXPERIMENTAL; Interventions: Other: Early pulmonary rehabilitation (EPR) | Intervention Type: OTHER; Name: Early pulmonary rehabilitation (EPR); Assigned to Arm(s): EPR
D: Arm Label: Activity-Self Management; Type: EXPERIMENTAL; Interventions: Behavioral: Self-Management and Motivational Interviewing | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Self-Management and Motivational Interviewing; Assigned to Arm(s): Activity-Self Management

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: DETermination of the Role of OXygen in Suspected Acute Myocardial Infarction (DETO2X-AMI) Based on the SWEDEHEART Registry
Brief Summary: The use of supplemental oxygen in the setting of suspected acute myocardial infarction (AMI) is manifested in international treatment guidelines and established in prehospital and hospital clinical routine throughout the world.

However, to date there is no conclusive evidence from adequately designed and powered trials supporting this practice. Existing data is conflicting and failing to clarify the role of supplemental oxygen in AMI.

The DETO2X-AMI trial is designed to shed light on this important issue.


Options:
A: Arm Label: Low oxygenation target; Type: EXPERIMENTAL; Interventions: Drug: Oxygen | Arm Label: High oxygenation target; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxygen | Intervention Type: DRUG; Name: Oxygen; Assigned to Arm(s): Low oxygenation target | Intervention Type: DRUG; Name: Oxygen; Assigned to Arm(s): High oxygenation target
B: Arm Label: No oxygen; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Oxygen; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxygen | Intervention Type: DRUG; Name: Oxygen; Assigned to Arm(s): Oxygen
C: Arm Label: Oxygen reduction; Type: EXPERIMENTAL; Interventions: Drug: Oxygen | Arm Label: Standard Care; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxygen | Intervention Type: DRUG; Name: Oxygen; Assigned to Arm(s): Oxygen reduction, Standard Care
D: Arm Label: Liberal Oxygenation (LO) group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Modulation of Inspired Fraction of Oxygen (FiO2) | Arm Label: Conservative Oxygenation (CO) group; Type: EXPERIMENTAL; Interventions: Drug: Modulation of Inspired Fraction of Oxygen (FiO2) | Intervention Type: DRUG; Name: Modulation of Inspired Fraction of Oxygen (FiO2); Assigned to Arm(s): Conservative Oxygenation (CO) group, Liberal Oxygenation (LO) group

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: DETermination of the Role of OXygen in Suspected Acute Myocardial Infarction (DETO2X-AMI) Based on the SWEDEHEART Registry
Brief Summary: The use of supplemental oxygen in the setting of suspected acute myocardial infarction (AMI) is manifested in international treatment guidelines and established in prehospital and hospital clinical routine throughout the world.

However, to date there is no conclusive evidence from adequately designed and powered trials supporting this practice. Existing data is conflicting and failing to clarify the role of supplemental oxygen in AMI.

The DETO2X-AMI trial is designed to shed light on this important issue.


Options:
A: Arm Label: Post op care; Type: ACTIVE_COMPARATOR; Interventions: Other: Oxygen delivery, Other: Oxygen administration | Arm Label: Oxygen administration- different %; Type: ACTIVE_COMPARATOR; Interventions: Other: Oxygen administration | Intervention Type: OTHER; Name: Oxygen delivery; Assigned to Arm(s): Post op care | Intervention Type: OTHER; Name: Oxygen administration; Assigned to Arm(s): Oxygen administration- different %, Post op care
B: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxygen | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxygen | Intervention Type: DRUG; Name: Oxygen; Assigned to Arm(s): A, B
C: Arm Label: Oxygenation, rigorous normal; Type: EXPERIMENTAL; Interventions: Drug: Oxygen | Arm Label: Oxygen, free conventional; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Oxygen; Assigned to Arm(s): Oxygenation, rigorous normal
D: Arm Label: No oxygen; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Oxygen; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxygen | Intervention Type: DRUG; Name: Oxygen; Assigned to Arm(s): Oxygen

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: DETermination of the Role of OXygen in Suspected Acute Myocardial Infarction (DETO2X-AMI) Based on the SWEDEHEART Registry
Brief Summary: The use of supplemental oxygen in the setting of suspected acute myocardial infarction (AMI) is manifested in international treatment guidelines and established in prehospital and hospital clinical routine throughout the world.

However, to date there is no conclusive evidence from adequately designed and powered trials supporting this practice. Existing data is conflicting and failing to clarify the role of supplemental oxygen in AMI.

The DETO2X-AMI trial is designed to shed light on this important issue.


Options:
A: Arm Label: 1; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Device: AO Therapy (aqueous oxygen) | Intervention Type: DEVICE; Name: AO Therapy (aqueous oxygen); Assigned to Arm(s): 2
B: Arm Label: Oxygen therapy; Type: OTHER; Interventions: Other: Oxygen therapy | Arm Label: No oxygen therapy; Type: OTHER; Interventions: Other: No oxygen therapy | Intervention Type: OTHER; Name: Oxygen therapy; Assigned to Arm(s): Oxygen therapy | Intervention Type: OTHER; Name: No oxygen therapy; Assigned to Arm(s): No oxygen therapy
C: Arm Label: No oxygen; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Oxygen; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxygen | Intervention Type: DRUG; Name: Oxygen; Assigned to Arm(s): Oxygen
D: Arm Label: Nasal oxygen; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nasal oxygen | Arm Label: Nasal Air; Type: PLACEBO_COMPARATOR; Interventions: Drug: Regular nasal air | Intervention Type: DRUG; Name: Nasal oxygen; Assigned to Arm(s): Nasal oxygen | Intervention Type: DRUG; Name: Regular nasal air; Assigned to Arm(s): Nasal Air

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy of Conservative Versus Surgical Therapy for Carpal Tunnel Syndrome: a Randomised Clinical Trial
Brief Summary: It is a randomized clinical trial comparing surgical and conservative (physical therapy) treatments for women with carpal tunnel syndrome (CTS). The purpose of the study is to determine the efficacy of physical therapy versus endoscopic surgery in pain and disability in women with carpal tunnel syndrome at medium and long-term follow-up periods. We hypothesized that proper physical therapy approach can be equally effective than surgical intervention for improving pain and function in patients with carpal tunnel syndrome.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Procedure: Early Carpal Tunnel Release for Mild or Moderate CTS, Other: MR Nerve Imaging for CTS | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Early Carpal Tunnel Release for Mild or Moderate CTS, Other: MR Nerve Imaging for CTS | Intervention Type: PROCEDURE; Name: Early Carpal Tunnel Release for Mild or Moderate CTS; Assigned to Arm(s): 1, 2 | Intervention Type: OTHER; Name: MR Nerve Imaging for CTS; Assigned to Arm(s): 1, 2
B: Arm Label: Tocilizumab + Methotrexate; Type: EXPERIMENTAL; Interventions: Drug: methotrexate, Drug: tocilizumab [RoActemra/Actemra] | Arm Label: Tocilizumab + Placebo Methotrexate; Type: ACTIVE_COMPARATOR; Interventions: Drug: placebo MTX, Drug: tocilizumab [RoActemra/Actemra] | Arm Label: Methotrexate + Placebo Tocilizumab; Type: ACTIVE_COMPARATOR; Interventions: Drug: methotrexate, Drug: placebo TCZ | Intervention Type: DRUG; Name: methotrexate; Assigned to Arm(s): Methotrexate + Placebo Tocilizumab, Tocilizumab + Methotrexate | Intervention Type: DRUG; Name: placebo MTX; Assigned to Arm(s): Tocilizumab + Placebo Methotrexate | Intervention Type: DRUG; Name: placebo TCZ; Assigned to Arm(s): Methotrexate + Placebo Tocilizumab | Intervention Type: DRUG; Name: tocilizumab [RoActemra/Actemra]; Assigned to Arm(s): Tocilizumab + Methotrexate, Tocilizumab + Placebo Methotrexate
C: Arm Label: Conservative group; Type: EXPERIMENTAL; Interventions: Other: Conservative group | Arm Label: Surgical group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Surgical group | Intervention Type: OTHER; Name: Conservative group; Assigned to Arm(s): Conservative group | Intervention Type: PROCEDURE; Name: Surgical group; Assigned to Arm(s): Surgical group
D: Arm Label: Methylprednisolone 80 mg; Type: EXPERIMENTAL; Interventions: Drug: Methylprednisolone 80 mg | Arm Label: Methylprednisolone 40 mg; Type: EXPERIMENTAL; Interventions: Drug: Methylprednisolone 40 mg | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Saline | Intervention Type: DRUG; Name: Methylprednisolone 80 mg; Assigned to Arm(s): Methylprednisolone 80 mg | Intervention Type: DRUG; Name: Methylprednisolone 40 mg; Assigned to Arm(s): Methylprednisolone 40 mg | Intervention Type: OTHER; Name: Saline; Assigned to Arm(s): Placebo

Answer: C